Abstract

No abstract

Highlights

  • Chronic heart failure (HF) is a major emerging healthcare problem, associated with a high morbidity and mortality

  • The use of Left ventricular assist devices (LVADs) is associated with a high risk of complications

  • Our material of scientific research consist of 23 patients, whose was operate in period autumn 2016–2017 year on implanted ventricle assist device in Silesian Centre for Heart Diseases

Read more

Summary

Introduction

Chronic heart failure (HF) is a major emerging healthcare problem, associated with a high morbidity and mortality. Sensitivity at heparin treatment in patients after LVAD implantation in early post operation period Left ventricular assist devices (LVADs) have emerged as a successful treatment option for patients with end-stage HF.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call